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A B S T R A C T
Background
Cohort studies are recommended for understanding ethnic disparities in cardiovascular
disease. Our objective was to review the process for identifying, including, and excluding ethnic
minority populations in published cardiovascular cohort studies in Europe and North America.
Methods and Findings
We found the literature using Medline (1966–2005), Embase (1980–2001), Cinahl, Web of
Science, and citations from references; consultations with colleagues; Internet searches; and
RB’s personal files. A total of 72 studies were included, 39 starting after 1975. Decision-making
on inclusion and exclusion of racial/ethnic groups, the conceptual basis of race/ethnicity, and
methods of classification of racial/ethnic groups were rarely explicit. Few publications provided
details on the racial/ethnic composition of the study setting or sample, and 39 gave no
description. Several studies were located in small towns or in occupational settings, where
ethnic minority populations are underrepresented. Studies on general populations usually had
too few participants for analysis by race/ethnicity. Eight studies were explicitly on Caucasians/
whites, and two excluded ethnic minority groups from the whole or part of the study on the
basis of language or birthplace criteria. Ten studies were designed to compare white and
nonwhite populations, while five studies focused on one nonwhite racial/ethnic group; all 15 of
these were performed in the US.
Conclusions
There is a shortage of information from cardiovascular cohort studies on racial/ethnic
minority populations, although this has recently changed in the US. There is, particularly in
Europe, an inequity resulting from a lack of research data in nonwhite populations. Urgent
action is now required in Europe to address this disparity.
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Introduction
Cardiovascular disease is the most common cause of
death in most industrialised societies and is either the
leading or a dominant cause of death for all racial and
ethnic groups in the US and the UK. The risk is especially
high amongst those originating from the Indian subcon-
tinent—South Asians [1].
Research on ethnic group differences and similarities may
potentially help advance understanding of the relationships
between risk factors and cardiovascular disease. Cardiovas-
cular cohort studies have been one of the key approaches for
achieving such understanding [2,3]. Most such studies started
after World War II, when coronary heart disease mortality
increased in many western countries [2]. This period
coincided with an expansion of migration from developing
to industrialised countries, leading to a marked increase in
ethnic diversity in Europe and North America in the late
20th century (http://www.migrationinformation.org/
GlobalData/countrydata/data.cfm). The inclusion of minority
groups in such cohort studies is important not only to
compare differences in health status between groups but also
to assess risk factor-outcome relationships within such
groups. Levy [3] has called for cohort studies to seek answers
to ethnic disparities in cardiovascular risks identiﬁed in
cross-sectional work, while Bhopal and Senior have outlined
the problems and potential of ethnicity as an epidemiological
variable [4].
The main objective of this review was to identify how the
major cardiovascular cohort studies in North America and
Europe included or excluded ethnic minority populations.
The methods and aims of this review could be extended, but
these geographical areas were chosen because cardiovascular
cohort studies have been pioneered by groups in these
locations [2].
There is no clearly deﬁned line between what is, and what is
not, a cardiovascular cohort study, and individual judgment is
required to make that determination. For the purposes of this
review, cardiovascular cohort studies were deﬁned as pro-
spective studies in deﬁned populations, with a primary aim of
studying risk factor-outcome relationships for major diseases
such as stroke and coronary heart disease. Studies included
are summarised in Table S1 [5–76].
Cohort studies with a multipurpose aim, those focused
on other diseases, and those arising from studies originally
designed as cross-sectional surveys or trials were generally
excluded, as were studies of populations in which the
investigators had little or no control over the sample (e.g.,
volunteers), although they may have yielded some cardio-
vascular data. A list of the studies that were given careful
consideration but excluded, with reasons given, is in Table
S2. Our reasoning for focusing on cardiovascular cohort
studies, in addition to personal and academic interest, was
this: Ethnic variations in cardiovascular disease give a clear
rationale for inclusion of ethnic and racial minority
groups, which may not be present for other conditions.
This review may help health and research policy makers
and the research community to judge whether there is
equity, by which we mean needs of different populations
have been met equally well, and, if not, whether we need
new studies.
Methods
Search Strategy
The starting point was a preliminary list prepared by RB in
1999. Both authors searched for studies independently
between the period April 2000 through September 2005,
using a variety of sources and repeated searches. Articles were
identiﬁed using the electronic databases Medline (1966–2001,
repeated in 2003 and 2005), Embase (1980–2001), Web of
Science, and Cinahl using the following keywords: ‘‘cardio-
vascular disease’’ or ‘‘atherosclerosis’’ or ‘‘coronary heart
disease,’’ and ‘‘cohort studies’’ or ‘‘epidemiological studies’’
or ‘‘prospective studies’’. The search was repeated with the
words ‘‘ethnicity’’ or ‘‘ethnic groups’’ or ‘‘racial groups’’
added. In Medline the search used free text and MESH terms.
This led to more than 150 references in each database. The
keywords ‘‘ethnicity and cardiovascular disease’’ used in the
Web of Science database yielded more than 300 references.
We examined the bibliographies of retrieved articles such as
the meta-analysis of prospective observational studies by the
Oxford Collaborative Group [2], and searched the Internet
using the search engine Google and the Web sites of the
British Medical Journal, National Research Register, Medical
Research Council, and National Heart, Lung, and Blood
Institute. Also, the names of speciﬁc cohort studies were
keyed into the Internet search engines, e.g., for the Athero-
sclerosis Risk in Communities (ARIC) Study. Finally, col-
leagues were consulted, RB’s literature ﬁles were examined,
and referees pointed to additional studies. Grey literature
(unpublished reports and abstracts) and editorial corre-
spondence were not included.
The search was limited at the outset to papers in English, as
the authors cannot read other languages and most major
cohort studies are published in English-language journals.
Database ﬁlters for English papers only were not applied.
Papers with titles in non-English languages were not
considered further. Although a count of such papers was
not made, our impression is that they were few. Nonetheless,
it is unlikely that any important European studies published
in languages other than English have been missed. At the
Migrant Health in Europe International Conference held in
Rotterdam in 2004, RB led a workshop discussing the
potential development of a European multiethnic cardiovas-
cular cohort study. Separately, RB presented this paper. The
audience of knowledgeable participants were unaware of
similar studies in Europe. At the conference many papers on
cardiovascular diseases were presented, but none reported
such studies. Professor Marc Bruijneels has collected infor-
mation across Europe, for a proposed European project to
compile data by ethnic group but he found no cardiovascular
cohort data by ethnic group (personal communication).
Studies were eligible for consideration that were de-
signed to examine prospectively the relationship between
risk factors and cardiovascular disease outcomes (coronary
heart disease and stroke) in population samples. By
population samples we mean natural living populations
and exclude studies of people with existing diseases. In view
of the nature of this study reﬂecting how investigators
made decisions on who to include and exclude in the
sample, studies without a sampling frame based on
volunteers were excluded, as investigators would have little
decision-making latitude in such circumstances. Some
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studies were concerned with multiple outcomes, and where
publications showed an emphasis on cardiovascular diseases
these were included, e.g., the Nurses Health Study [63].
Cohort studies where the sample was deﬁned retrospec-
tively based on records (investigators have limited choices
over sampling and on ethnic coding in such studies), trials,
cross-sectional studies, case control studies, and studies
based solely on routine statistics were excluded. Inclusion
decisions required a degree of judgment and ﬂexibility
because, as stated above, there is no ﬁrm deﬁnition for a
cardiovascular cohort study. Furthermore, investigators
themselves conducted and analysed their studies ﬂexibly,
and assessing the study design was not always easy, e.g., with
follow-up of studies that were originally cross-sectional. We
also followed advice from referees, e.g., The Women’s
Health Initiative observational study was included, although
a major component of this study is a trial. Multiple Risk
Factor Intervention Trial (MRFIT) was designed as a trial,
although it contained an observational component (with
volunteer samples), and was excluded. Studies designed to
study cancer, e.g., the European Prospective Investigation
of Cancer (EPIC) [77] and the Multi-Ethnic Los Angeles
Cohort Study, were excluded (Table S2), although such
studies may shed light on cardiovascular diseases.
In total, 72 cardiovascular cohort studies in the US/North
America and Europe were included. This review focused on
papers describing the design and rationale of the study. For
example, the Framingham Study has hundreds of secondary
papers, but a few discussing methods were identiﬁed. This
approach is justiﬁed on both scientiﬁc and pragmatic
grounds. Scientiﬁcally, inclusion/exclusion of particular
populations is a design issue that is handled at the planning
stage. Pragmatically, it would have been inefﬁcient to
examine multiple papers for information that ought to be
provided in the baseline paper. Only one paper per study is
cited here, although sometimes several were examined.
Studies based on combining existing cohorts, e.g. the Sleep,
Heart and Health Study (Table S2), are not included here, but
the original studies are when appropriate.
Research Questions and Data Extraction
The research questions that guided data collection from
the studies are listed in Table 1. Information extracted from
publications was directly entered into Table S1. Both authors
independently examined all the papers with virtually com-
plete agreement. The few disagreements were resolved by
conferring.
Terminology and Concepts of Race and Ethnicity
Wherever possible and appropriate, the terminology used
for ethnic group classiﬁcation has been quoted directly from
the paper, even when this is not in agreement with currently
accepted terminology and is potentially offensive. Similarly,
we have accepted the concepts of race and ethnicity
provided by authors, but for reasons discussed by Senior
and Bhopal we have tended to use the word ethnicity rather
than race, and we apply the concepts as discussed in their
paper [4].
Our use of the term nonwhite reﬂects our focus on
populations that do not have European ancestral origins
(described, using current conventions, as white), and would
not describe themselves, or be perceived as, white. This focus
reﬂects long-standing, widespread concern about inequities
in health and health care that are particular to such
populations.
Results
Overview
The main aim of each study, with slight variations, was to
determine the incidence of coronary heart disease and/or
stroke and study risk factor-outcome relationships.
Table 2 summarises and Table S1 lists the 72 studies
included [5–76]. The studies started between 1946 and 2000,
with 39 starting after 1975, by which time ethnic minority
populations were becoming well established in Western
Europe (http://www.migrationinformation.org/GlobalData/
countrydata/data.cfm), and knowledge of ethnic variations
in cardiovascular disease was appearing in Europe. Studies
numbered 41 in Europe, 31 in North America, and one (the
Seven Countries study) in both. Ten studies were designed to
compare white and nonwhite populations, while ﬁve studies
focused on one nonwhite racial/ethnic group; all 15 of these
were conducted in the US.
Studies seldom provided details on the racial or ethnic
composition of the study setting or sample, and when they
did the details were minimal; 39 gave no description at all.
Several studies were located in small towns or in occupational
settings, whereas minority populations tend to live in cities
and work in a restricted range of workplaces. The inves-
tigators in some studies saw the population homogeneity of
such locations as valuable. Studies that were based on general
populations usually had too few participants for analysis by
race or ethnicity. The process by which decisions on inclusion
and exclusion of racial/ethnic groups were rarely made
explicit. Eight studies explicitly stated they were on Cauca-
sians or whites, and two excluded ethnic minority groups
using language and birthplace criteria. One study [61]
excluded the nonwhite population (6,236 people) from the
incidence component of the research because of small
numbers and low response rates to mailed questionnaires.
There were other examples of studies including ethnic
minority groups in the baseline phase of the study but
reporting cohort analyses in the white population. There
were major differences in the extent of inclusion of minority
groups between Europe and the US.
Table 1. Research Questions
Which cardiovascular cohort studies have been done in Europe and North Ameri-
ca?
Have the researchers discussed in their publication the ethnic composition of
the general population in which these studies have been done?
How did the investigators report making the decision on which ethnic groups
should be included?
What is the reported ethnic composition of the sample?
How did the investigators report assessing people’s ethnicity?
Was analysis done in terms of ethnicity and reported?
What are the consequences of this in terms of equality both in terms of research
and health care?
DOI: 10.1371/journal.pmed.0030044.t001
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Europe
None of the studies done in Europe mentioned studying
nonwhite racial or ethnic variations in their aims. The ethnic
composition of the source population for the sample was not
described or discussed, but sometimes the text showed
awareness of the issue of ethnic heterogeneity; e.g., the Paris
Prospective Study [12] was explicitly of native-born French
men, while the Second Manifestations of ARTerial disease
(SMART) study [43] was of Dutch speakers. Two studies
intended to examine European origin ethnic groups. The
Yugoslavia Cardiovascular Disease Study [7] contrasted
Muslim and Roman Catholic populations, but there was little
detail on their characteristics. The Cardiovascular Disease in
Norwegian Counties Study [21] collected information by
ethnic group but provided no analysis on this variable. Few
authors speciﬁed the ethnic composition of their sample, and
when they did it was usually with the label Caucasian or white
with no or sparse detail on the assignment of ethnic/racial
group.
North America
Most North American studies gave some attention to the
issue of ethnicity and race, usually in relation to the sample
rather than the racial/ethnic composition of the setting of the
study. The assignment of racial/ethnic group, and its validity,
were not made explicit. Five studies focused on one nonwhite
group: the Meharry Cohort Study [50] focused on African-
American students; the Jackson Heart Study [75] focused on a
black population; the Gila River Indians Community Study
[65] studied adult American Indians (Pimas), as did the Strong
Heart Study (12 American Indian tribes in Arizona, Oklaho-
ma and North and South Dakota) [66]; and the NI-HON-SAN
project [55] studied adults of Japanese origins, comparing
American and Japanese locations.
Ten studies compared one or more ethnic groups simulta-
neously: the Evans County Study [52], the ARIC study [69], and
the Charleston Heart Study [53] compared black and white
adults; the CARDIA Study [67] compared black and white
students; the Bogalusa Heart Study [60] compared black and
white school children; the San Antonio Heart Study compared
cardiovascular risk factors in Mexican Americans and Anglos
[68]; the National Health and Nutrition Examination Survey
(NHANES) [57], the Multi-Ethnic Prospective Cohort [62], the
Women’s Health Initiative [73], and the Multi-Ethnic Study of
Atherosclerosis [76], were multiethnic studies.
Discussion
The study of ethnic variations in disease is long established,
with a research base founded in the 19th century and
strengthening in the 20th century, particularly in North
America. The cardiovascular research community has been
aware for some decades of important variations in the
frequency, causes and consequences of cardiovascular dis-
eases in non-European origin ethnic minority populations.
Well-publicised government reports and academic papers
discussed these issues in the mid-1970s and 1980s, e.g., heart
attacks in East London were shown to be high in Asians
(mainly from the Indian subcontinent) and low in Caribbeans
[78]. Mortality rates may vary threefold or more between
minority ethnic groups; e.g., in a comparison of Chinese and
South Asian populations living in the UK [1], the variations
were much larger than those among white minority pop-
ulations, e.g., the Irish-born people living in England and
Wales compared to the whole population there [79]. There is
no published major cohort study focusing on ethnic group
variations in Europe, but a growing information base is
developing in North America. This observation is important
for both policy and practice. For example, risk prediction
models have been developed from data on white European
origin populations, and their unreliability in relation to
racial/ethnic minority groups is recognised [80, 81]. Within
the cardiovascular ﬁeld there is also concern about possible
racial disparities in health care and outcomes [82,83]. Ethnic
minority groups in the US and in Europe are ‘‘at-risk’’ of
differential treatment, particularly for surgical therapies, and
several explanations, including institutional discrimination,
are being pursued [83]. The decisions of most individual
investigators undertaking cohort studies to concentrate on
white European origin populations may have been scientiﬁ-
cally sound and well meant, but collectively, especially in
Europe but also for some ethnic groups in the US, it may have
resulted in a lack of attention to the needs of nonwhite
populations.
Table 2. Summary of Key Findings in Table S1: Inclusion and Exclusion of Racial/Ethnic Minorities in Cardiovascular Cohort Studies
Category Europe North America Both
Number of studies examined 41 31 72
No description or discussion of study in relation to ethnicity or race
(in practice on white or predominantly white populations)
33 [5,6,8–11,13–15,17–20,22–25,27–35,37,39–45] 6 [48,54,64,70–72] 39
Study population explicitly ‘‘Caucasian’’ or ‘‘white’’ 3 [26,36,38] 4 [47,51,59,63] 7
Analysis of data restricted to white population 1 [16] 4 [47,56,58,61] 5
Explicitly select out racial/ethnic minority groups by language,
birthplace, or other criteria at recruitment
2 [12,43] 0 2
Population sample but set in locations—small towns/workplaces—where
racial/ethnic minorities are likely to be underrepresented
7 [6,8,13,22,29,32,33] 4 [48,49,51,64] 11
Designed to compare European-origin ethnic groups 2 [7,21] 0 2
Designed to focus on one nonwhite racial/ethnic groups (comparisons with
existing studies)
0 5 [50,55,65,66,75] 5
Compare nonwhite racial/ethnic groups simultaneously 0 10 [52,53,57,60,62,67–69,73,76) 10
Numbers in brackets are references.
DOI: 10.1371/journal.pmed.0030044.t002
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Limitations of This Study
Since this review was limited to papers published in
English, there was the potential to miss relevant, large-scale
cardiovascular cohort studies in Europe and North America
published in other languages. The reference lists of papers
examined did not, however, cite them, and consultations
around Europe did not identify them (see Methods). Bias
from such omissions, if any, is unlikely to alter the
conclusions of this paper. One or a few papers from each
study, usually those giving adequate detail on the rationale
and design of the study (sample, participants, methods used,
etc.), were studied. Secondary papers may mention ethnic
groups, as in the Whitehall Study, where cross-sectional
analyses were done [84]. This said, the papers we studied
clariﬁed the primary intentions and design of each study. It is
axiomatic that unless the race/ethnicity component is
considered at the design stage, and the ethnic group of
participants is identiﬁed, useful data on this issue are unlikely
to accrue later. Our search strategy, which excluded manual
searching of journals, may have missed some studies, as was
also acknowledged by The Prospective Studies Collaboration
[2]. It would be an inefﬁcient, and possibly futile, exercise to
catalogue every study, especially as several cohorts have led to
hundreds of papers. However, to our knowledge, this is the
most complete list of cardiovascular cohort studies available.
We have excluded small-scale studies that were combined to
create a cohort, e.g., the Italian RIFLE project consisting of 45
‘‘cohorts’’ and a total sample of 32,726. There is no mention
of race or ethnicity in the paper [85]. It is improbable that
such small individual studies included the ethnic dimension.
The studies included meet the highest standards, as indicated
by publication in journals indexed by electronic databases.
There are many other cohort studies that are multipurpose or
focus on noncardiovascular diseases. In theory these could
potentially yield data on ethnic variations in cardiovascular
diseases. Our assessment of such studies suggests that they
give no more detail on the racial/ethnic issues than those we
have examined (Table S2). For example, the EPIC-Norfolk
study did not discuss ethnicity [77].
Unpublished (grey) literature has not been included in this
review, with the exception of the Jackson Study [75], which
links to the published ARIC study and is fully described on a
website. This exception was made because of its obvious
importance. We are aware of some cross-sectional studies
(generally small) that are designed with linkage to mortality
follow-up, e.g., the Southall Study [86] and the Newcastle
Heart Project [87], that will publish risk factor-outcome data
in due course. These were, however, designed with the power
for cross-sectional and not cohort analyses. A cohort study of
Indian Asians in West London is ongoing (Jaspal Kooner,
personal communication), but this study will not address the
needs of other minority ethnic groups in the UK. There are
also many studies designed as trials that have long-term
follow-up and provide opportunities for cohort type analysis,
e.g., MRFIT [88]. Analysis of inclusion and exclusion of ethnic
minority populations in trials and other study designs was
beyond the scope of this study, although it may be that the
ﬁndings will be similar. Further research on cardiovascular
trials, cross-sectional studies, and case-control studies might
be illuminating. These limitations do not, however, alter our
main conclusions.
Interpretation of Main Results
The review answered the research questions (Table 1).
There are many cardiovascular cohort studies, indicating
their perceived and actual importance. The ethnic compo-
sition of the population where the studies were based, and
the process of inclusion/exclusion of ethnic minority groups,
was not a point of emphasis in publications. Many studies
gave little or no data on the ethnic composition of the
sample, or the description was limited and based on ethnic
group labels. With the exemplary exception of the San
Antonio study, which developed an algorithm based on a
range of data, studies did not provide details of the processes
for ethnic coding. Cohort-based analysis by ethnic group is
available in the US for a number of ethnic groups, but not in
Europe.
Although the sample size may be too small to produce
analysis by ethnic group, inclusion of minority populations is
still important. Such cohorts are population-based and
should be generalisable to populations similar to that from
which the sample has been drawn; without information on
ethnic composition, generalisability becomes more difﬁcult.
Such studies can also provide a foundation for larger studies
focusing on minority populations, and potentially could lead
to analysis by ethnic group after pooling of data.
Analysis of data by ethnic group requires adequately
powered studies, and these will be large-scale, expensive, and
challenging. Such studies will be funded only when there is
agreement on the need for them. There are more than 30
European cohort studies, many started within the last 20
years when ethnic variations were already described, yet
collectively or singly they are unable to provide analysis by
ethnic group. This paper contributes to the needs assess-
ment.
Many cohort studies have focused on white populations
despite being set in multiracial/ethnic nations and regions
(http: / /www.migrationinformation.org /GlobalData /
countrydata/data.cfm). This is especially so in European
studies, e.g., those set in major cities such as London,
Amsterdam, and Paris. This observation applies to studies
started after the mid-1970s when understanding about the
needs of minority groups was substantial, many cohort
studies on white populations were in place, and knowledge
about causes and control of cardiovascular disease in white
populations was already advanced. The studies that were
designed to study racial/ethnic minority groups were all in the
US, and were started more recently, in response to an
increasing recognition of the needs of ethnic minorities.
Some studies were openly exclusive, e.g., including only the
native born or native language speakers, or simply being
conﬁned to whites/Caucasians. Some studies used members of
occupational groups as study participants. This can lead to
exclusion of minority populations, perhaps unwittingly, in
that unemployment is usually higher in ethnic minority
populations, some of which have comparatively high levels of
self-employment and employment in small workplaces and
are less likely to be a substantial proportion of the work force
of large employers [89]. While recruiting randomly is,
arguably, fair, it rarely permits analyses by ethnic group,
because the resultant sample size is too small, except for
European-origin populations. This can lead to incidence data
analyses in white populations and more limited analysis, e.g.,
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cross-sectional in ethnic minority groups [84]. By choosing
small towns or rural areas, as their base, as in the
Framingham, Tecumseh, Seven Countries, Caerphilly, and
British Regional Heart Studies, investigators gain population
stability and homogeneity but miss multiethnic populations
living predominantly in inner city areas, where the cardio-
vascular disease prevention challenge is greatest. In these
circumstances there is a case for more purposive sampling,
including weighting the sample to augment the number of
ethnic minority participants. Studies that started after 1975
and which, in retrospect, might have been designed in this
way include Whitehall 2, Rotterdam Elderly Study, British
Women’s Heart and Health Study, Nurses Health Study, Iowa
Women’s Health Study, and the Health Professionals Heart
Study. With the exception of black/white comparisons, the
opportunity for multiethnic comparison has not been fully
exploited, although several recent studies in the US promise a
truly multiethnic approach.
Explanations for the ﬁndings here include scientiﬁc
pragmatism, shortage of resources, potential difﬁculties in
accessing populations and in gaining informed consent,
insufﬁcient expertise and experience, lack of interest, a
resistance to dividing populations by ethnic or racial status
(particularly in some countries of mainland Europe), and the
possibility of indirect or direct discrimination. In many ways
the issues highlighted echo those applying to women until
recently. These explanations require further analysis and
research.
Data are vital to assess the needs of ethnic minority groups;
to implement, evaluate, and adjust the necessary health
policies; and to provide excellent clinical care based on valid
risk prediction models. The Race Relations (Amendment) Act
2000 in the UK [90] and laws in Europe will mandate a change
of strategy for all public sector organisations, including those
that commission or fund research, such as the Medical
Research Council. In the US, the NIH Strategic Research Plan
(2002–2006) promises to spearhead further change, building
on previous NIH policies [91]. This paper indicates that
researchers in the US have responded to NIH policies
promoting the inclusion of ethnic minority populations in
research. Studies exploring ethnic variations may lead to
insights that are generalisable to the whole population, in
terms of both disease causation and the effectiveness of
interventions and healthcare systems. Inclusion of ethnic
minorities groups in research, therefore, is likely to beneﬁt
the whole population.
A Lancet commentary has called for cohort studies in
such groups [3]. The traditional approach, whereby re-
searchers’, peer reviewers’, and funding bodies’ interests
drive the research agenda, needs to be balanced by a
strategic needs-based approach if the inequity described in
this paper is to be addressed. The planned Biobank UK
study of a cohort of 500,000 people in the UK offers an
opportunity to redress the gap in the UK—but only if it
achieves its stated goals of recruiting ethnic minority
groups with due emphasis on population heterogeneity,
attention to cross-cultural comparability of data, and high
retention of ethnic minority populations in the cohort
(http://www.ukbiobank.ac.uk/). This paper raises broader
questions that merit debate on how the research community
responds to the increasing ethnic diversity of populations
internationally.
Supporting Information
Table S1. Cardiovascular Cohort Studies Included by Area of Study
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Patient Summary
Background. As a result of migration, mostly for economic reasons,
populations in many countries around the world are becoming
increasingly diverse. In many cases, ethnic minorities differ in their
socio-economic circumstances, culture, lifestyle, and genetic make-up
from the majority population (and there are, of course, also differences
within the majority group and within minority groups). These differences
in risk factors (such as diet and smoking) can influence a person’s
susceptibility to disease. For some diseases, such as heart disease, it is
well known that particular ethnic groups are at higher risk than others. It
is not always clear, though, whether this high risk is due to socio-
economic circumstances, culture, genes, lifestyle, or a combination of
these factors.
Why Was This Study Done? Cardiovascular disease, which can cause
heart attacks and strokes, is the most common cause of death in the US
and most European countries. Rates of cardiovascular diseases vary
substantially between different countries, and also between different
ethnic groups in ethnically diverse countries such as the UK and the US.
Researchers and health policy makers need to understand more about
the variations in cardiovascular disease. To ensure the best possible
health care for the entire population, they need to know how exactly the
risks differ between different ethnic groups and what causes those
differences. One key research tool to address these questions are so-
called cohort studies (a cohort refers to a specific group of people that
are studied over time). Cohort studies are ‘‘forward looking’’—they
typically enroll a large number of healthy participants who are then
followed over a number or years to study long-term health outcomes.
Over the past decades, a number of cohort studies have focused on
cardiovascular disease. In this study, researchers wanted to find out
whether these cohort studies included or excluded ethnic minority
groups.
What Did the Researchers Do and Find? They searched the medical
literature for cohort studies on cardiovascular disease. They found 72
that met their criteria and analyzed them in detail. The researchers
discovered that most of the cohort studies did not provide detailed
information on the ethnic composition of the broader populations from
which the participants were recruited. Most of them also did not state
whether minority groups were included in or excluded from the study.
Additionally, the researchers found that many of the studies did not give
details on the ethnic composition of the participants themselves, or on
how the participants’ ethnicity was determined. Studies with participants
that were representative of diverse populations usually were not large
enough to answer the kinds of questions necessary to determine
differences between different ethnic groups. However, ten of the studies
were designed specifically to compare white and nonwhite participants,
and five studies focused on nonwhite minority groups specifically. All 15
of those studies were done in the US.
What Does This Mean? Despite the knowledge that ethnicity matters in
cardiovascular disease, most cohort studies have not been designed to
further explore this connection. The situation in the US seems to be
changing, with a number of recent studies designed to add data on
cardiovascular disease risks and causes among minority populations. No
such studies have yet been reported in Europe. Research strategies in
Europe should be adjusted to meet this need.
Where Can I Find More Information Online? The following Web sites
provide information on minority participation in health research.
Office of Minority Health Research at the US National Heart, Lung, and
Blood Institute:
http://www.nhlbi.nih.gov/about/omha/
Center of Excellence in Minority Health and Health Disparities at Harvard
Medical School:
http://www.mfdp.med.harvard.edu/coe/
The Migration Information Source provides data on the composition of
the populations for many countries:
http://www.migrationinformation.org/
Department of Health, England:
http://www.dh.gov.uk/PolicyAndGuidance/EqualityAndHumanRights/fs/
en/
South Asian Health Foundation:
http://www.sahf.org.uk/events.html
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